Croda International reports third quarter sales rise

Croda International plc reported third quarter sales of £450 million, representing a 6.6% increase in constant currency terms and exceeding consensus estimates of £449 million by £1 million.

The company confirmed its full-year 2026 guidance for organic sales growth of 3% to 6%, with consensus at 5.0%. Adjusted operating profit expectations remained unchanged at approximately £322 million, in line with first quarter market expectations.

Consumer Care delivered sales of £266 million with constant currency growth of 10.8%, outperforming consensus by 340 basis points.

Beauty Actives grew 19% in constant currency, driven by strength in premium categories and increased demand for innovation from global beauty brands. Beauty Care rose 13% in constant currency, while Home Care advanced 10%.

Life Sciences posted sales of £135 million with constant currency growth of 1.8%, falling 340 basis points short of consensus. Pharma grew 5% in constant currency, reflecting continued growth in Pharma Ingredients and sequential improvement in Pharma Solutions. Seed Enhancement increased 12%, while Crop Protection declined 9% in constant currency due to weaker demand and pressure on farm incomes.

Industrial Specialties recorded sales of £48 million, with constant currency growth of negative 1.2%.

By region, Asia led with 12% organic sales growth, followed by Europe, Middle East and Africa at 6%, North America at 4%, and Latin America at 3%.